$MGNX
MACROGENICS INC Stock $mgnx

$mgnx Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000162828017011189 Filed on November 08, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$152.4M	$1.663M	$3.255M
YoY Change	2883.92%	-48.91%	-77.83%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$8.400M	$8.400M	$7.200M
YoY Change	-8.7%	16.67%	20.0%
% of Gross Profit
Research & Development	$39.00M	$40.98M	$30.30M
YoY Change	25.4%	35.28%	25.71%
% of Gross Profit
Depreciation & Amortization	$1.340M	$1.910M	$2.070M
YoY Change	-32.32%	-7.73%	322.45%
% of Gross Profit
Operating Expenses	$47.40M	$40.98M	$30.30M
YoY Change	17.62%	35.28%	0.65%
Operating Profit		-$47.72M	-$34.27M
YoY Change		39.28%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$800.0K	$681.0K	$419.0K
YoY Change	60.0%	62.53%
Pretax Income	$105.7M	-$47.00M	-$33.80M
YoY Change	-403.74%	39.05%	119.48%
Income Tax	$0.00
% Of Pretax Income	0.0%
Net Earnings	$105.7M	-$47.04M	-$33.85M
YoY Change	-403.96%	38.99%	119.18%
Net Earnings / Revenue	69.39%	-2828.8%	-1039.82%
Basic Earnings Per Share	$2.87	-$1.28	-$0.97
Diluted Earnings Per Share	$2.80	-$1.28	-$0.97
COMMON SHARES
Basic Shares Outstanding	36.82M shares	36.78M shares	34.77M shares
Diluted Shares Outstanding		36.78M shares	34.77M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$305.1M	$203.6M	$311.1M
YoY Change	10.14%	-34.55%	-14.95%
Cash & Equivalents	$211.7M	$90.88M	$109.9M
Short-Term Investments	$93.40M	$112.8M	$201.2M
Other Short-Term Assets	$3.600M	$3.700M	$2.100M
YoY Change	-14.29%	76.19%	5.0%
Inventory
Prepaid Expenses	$3.151M	$3.261M
Receivables	$13.64M	$2.194M	$3.000M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$322.3M	$209.5M	$316.3M
YoY Change	13.51%	-33.78%	-14.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$49.98M	$30.84M	$18.50M
YoY Change	178.29%	66.69%	60.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00	$3.000M
YoY Change	-100.0%	-100.0%
Other Assets	$1.602M	$1.541M	$2.100M
YoY Change	17.02%	-26.62%	0.0%
Total Long-Term Assets	$51.59M	$32.38M	$23.60M
YoY Change	88.85%	37.2%	73.53%
TOTAL ASSETS
Total Short-Term Assets	$322.3M	$209.5M	$316.3M
Total Long-Term Assets	$51.59M	$32.38M	$23.60M
Total Assets	$373.9M	$241.8M	$339.9M
YoY Change	20.12%	-28.85%	-11.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.451M	$1.680M	$1.400M
YoY Change	-38.65%	20.0%	-44.0%
Accrued Expenses	$38.58M	$25.50M	$15.40M
YoY Change	139.13%	65.59%	69.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K	$700.0K	$1.500M
YoY Change	-81.25%	-53.33%	-25.0%
Total Short-Term Liabilities	$49.76M	$32.44M	$22.10M
YoY Change	82.24%	46.78%	-1.34%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$700.0K
YoY Change	-100.0%	-100.0%	-78.13%
Other Long-Term Liabilities	$24.90M	$19.90M	$17.00M
YoY Change	67.11%	17.06%	-11.46%
Total Long-Term Liabilities	$24.90M	$19.90M	$17.70M
YoY Change	63.82%	12.43%	-20.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$49.76M	$32.44M	$22.10M
Total Long-Term Liabilities	$24.90M	$19.90M	$17.70M
Total Liabilities	$74.65M	$52.38M	$39.80M
YoY Change	75.59%	31.61%	-11.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$312.3M	-$418.1M
YoY Change	6.7%
Common Stock	$611.6M	$607.6M
YoY Change	8.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$299.2M	$189.5M	$300.1M
YoY Change
Total Liabilities & Shareholders Equity	$373.9M	$241.8M	$339.9M
YoY Change	20.12%	-28.85%	-11.51%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	$105.7M	-$47.04M	-$33.85M
YoY Change	-403.96%	38.99%	119.18%
Depreciation, Depletion And Amortization	$1.340M	$1.910M	$2.070M
YoY Change	-32.32%	-7.73%	322.45%
Cash From Operating Activities	$111.9M	-$31.35M	$49.79M
YoY Change	-494.81%	-162.96%	-751.7%
INVESTING ACTIVITIES
Capital Expenditures	-$10.75M	-$9.850M	-$1.980M
YoY Change	914.15%	397.47%	-24.14%
Acquisitions
YoY Change
Other Investing Activities	$19.40M	$14.31M	-$1.180M
YoY Change	527.83%	-1312.71%
Cash From Investing Activities	$8.640M	$4.470M	-$3.160M
YoY Change	325.62%	-241.46%	21.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	360.0K	1.150M	1.010M
YoY Change	-26.53%	13.86%	-99.28%
NET CHANGE
Cash From Operating Activities	111.9M	-31.35M	49.79M
Cash From Investing Activities	8.640M	4.470M	-3.160M
Cash From Financing Activities	360.0K	1.150M	1.010M
Net Change In Cash	120.9M	-25.73M	47.64M
YoY Change	-568.23%	-154.01%	-63.56%
FREE CASH FLOW
Cash From Operating Activities	$111.9M	-$31.35M	$49.79M
Capital Expenditures	-$10.75M	-$9.850M	-$1.980M
Free Cash Flow	$122.6M	-$21.50M	$51.77M
YoY Change	-549.58%	-141.53%	-1129.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001125345
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36822710	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MACROGENICS INC
	mgnx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-846000	USD
	mgnx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	6482000	USD
	mgnx	Number Of Lease NumberOfLease	5
	mgnx	Proceedsfrom Stock Options Exercised And Espp Purchases ProceedsfromStockOptionsExercisedAndESPPPurchases	1362000	USD
	mgnx	Proceedsfrom Stock Options Exercised And Espp Purchases ProceedsfromStockOptionsExercisedAndESPPPurchases	695000	USD
CY2016	mgnx	Reduction In Rd Expense ReductionInRDExpense	1300000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3995000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1680000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2764000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2194000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16134000	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25501000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-82000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-27000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	561198000	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	607191000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3856652	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3856652	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4533794	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4533794	shares
CY2016Q4	us-gaap	Assets Assets	311263000	USD
CY2017Q3	us-gaap	Assets Assets	241845000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	283947000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	209466000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	56000	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	12000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	138000	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	39000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	200966000	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	112790000	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	200884000	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	112763000	USD
CY2016Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	7986000	USD
CY2017Q3	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	0	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	196172000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109901000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	84098000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90884000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-86271000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6786000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34870607	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36807112	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	349000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	368000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	37520000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	111578000	USD
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	49387000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	132495000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	1319000	USD
CY2017Q3	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	1165000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4867000	USD
CY2017Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	11504000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4261000	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3202000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	10045000	USD
CY2017Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8438000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5634000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5886000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.97
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.69
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.28
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.50
CY2017Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	23700000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7224000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20596000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8403000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24249000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-133000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2138000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1784000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-570000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3895000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	9501000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4920000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2666000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	599000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-168000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-495000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-222000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-2473000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-1176000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	32438000	USD
CY2016Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	2014000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	82404000	USD
CY2017Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	1076000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	3435000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1362000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	34989000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-72283000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	69237000	USD
CY2016Q4	us-gaap	Investments Investments	192898000	USD
CY2017Q3	us-gaap	Investments Investments	112763000	USD
CY2017Q2	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P72M
CY2017Q3	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P30M
CY2016Q4	us-gaap	Liabilities Liabilities	42512000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	52380000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	311263000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	241845000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27302000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15350000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-97440000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-33846000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-23745000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-47043000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-125353000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-34265000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24804000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-47724000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-127112000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	52789000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	300000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	2400000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	4743000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4775000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	6342000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	6574000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	23370000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	6985000	USD
CY2016Q4	us-gaap	Other Assets OtherAssets	704000	USD
CY2017Q3	us-gaap	Other Assets OtherAssets	364000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1369000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1541000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-41000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	23000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	56000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	55000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	24.13
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-33887000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-23722000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3483000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.09
CY2017Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3261000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	34294000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-46987000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-125298000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0	USD
CY2017Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	175000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	419000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1059000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	681000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1759000	USD
CY2016	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2015Q3	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	5100000	USD
CY2017Q3	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	7500000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	1176000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	269697000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	89124000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10319000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18645000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	207733000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	177006000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	400000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17961000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30838000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30296000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	90982000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40984000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	108246000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	1891000	USD
CY2017Q3	us-gaap	Restructuring Reserve RestructuringReserve	715000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1593000	USD
CY2017Q3	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	715000	USD
CY2016Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	298000	USD
CY2017Q3	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	0	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-292714000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-418067000	USD
CY2016Q3	us-gaap	Revenue From Grants RevenueFromGrants	1241000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	4370000	USD
CY2017Q3	us-gaap	Revenue From Grants RevenueFromGrants	587000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	1948000	USD
CY2016Q3	us-gaap	Revenues Revenues	3255000	USD
	us-gaap	Revenues Revenues	86774000	USD
CY2017Q3	us-gaap	Revenues Revenues	1663000	USD
	us-gaap	Revenues Revenues	5383000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.02
CY2016Q3	us-gaap	Share Based Compensation ShareBasedCompensation	3003000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9126000	USD
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	4001000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11064000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2704057	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	16.86
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3700000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	304259	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1219725	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.56
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	18050000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3838060	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4533794	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.93
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.71
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	17993000	USD
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4352976	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	19.48
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	17254000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M19D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	10700000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	219732	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	268751000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	189465000	USD
CY2016Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34766440	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34629330	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	36779305	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35847449	shares
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34766440	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34629330	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	36779305	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35847449	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34766440	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34629330	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36779305	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35847449	shares

Files In Submission

Name	View Source	Status
0001628280-17-011189-index-headers.html	Edgar Link	pending
0001628280-17-011189-index.html	Edgar Link	pending
0001628280-17-011189.txt	Edgar Link	pending
0001628280-17-011189-xbrl.zip	Edgar Link	pending
exhibit31-1q32017.htm	Edgar Link	pending
exhibit31-2q32017.htm	Edgar Link	pending
exhibit32-1q32017.htm	Edgar Link	pending
exhibit32-2q32017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mgnx-093017x10q.htm	Edgar Link	pending
mgnx-20170930.xml	Edgar Link	completed
mgnx-20170930.xsd	Edgar Link	pending
mgnx-20170930_cal.xml	Edgar Link	unprocessable
mgnx-20170930_def.xml	Edgar Link	unprocessable
mgnx-20170930_lab.xml	Edgar Link	unprocessable
mgnx-20170930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MGNX
MACROGENICS INC Stock $mgnx

2017 Q4 Form 10-Q Financial Statement

#000162828017011189 Filed on November 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGNX MACROGENICS INC Stock $mgnx

2017 Q4 Form 10-Q Financial Statement

#000162828017011189 Filed on November 08, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MGNX
MACROGENICS INC Stock $mgnx